Rallis IndiaQ2 FY24

Rallis India Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹191.25P/E: 18.1Market Cap: ₹3.7K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 5

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 5
  • The global agrochemical business experienced rapid growth (from $60-65 billion to $80 billion in two years) but is currently facing inventory overhang and price correction, causing demand compression expected to last through Q3 and the financial year.
  • Volume-led growth is a priority, though pricing growth is likely negative in the near term.
  • Domestic industry growth is expected to be low single digit with flat to marginally positive volumes.
  • International business faces volume declines due to high channel inventories and pricing pressures, with normalization anticipated after Q3 but timing uncertain.
  • Seed business growth is positive with strong cotton hybrid sales; efforts continue to reduce seasonality and improve unit economics.
  • New product launches, ramp-up of multipurpose plants, and strategic pipeline development aim for steady consistent growth over the coming years.
  • Cost and margin management remain priorities to navigate volatile markets and sustain profitability.

See what Rallis India management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • No new fundraising through debt or equity is mentioned in the transcript.
  • The company has repaid Rs.100 crore of working capital loans during H1 FY24.
  • Post this repayment, Rallis India has become a zero-debt company except for a small sales tax deferral loan.
  • Capex for the year is envisaged to be around Rs.150 crore, indicating ongoing investments are likely to be funded internally.
  • No indication of plans for raising additional capital through equity or new debt issuance was shared during the call.

See what Rallis India management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company envisages capex spending of around Rs.150 crore for the year.
  • Focus on ramping up the multipurpose plant (MPP) at Dahej.
  • Continuous evaluation and potential expansion of capacity for Pendimethalin due to rising demand.
  • Investments made over the last few years in R&D, product development, manufacturing, and capabilities aimed at supporting long-term sustainable growth.
  • Plans to scale up contract manufacturing business progressively through better utilization of the new multi-purpose plant.
  • Introduction of new technical products like Difenoconazole and upcoming commercialization of new CSM products from MPP expected to contribute to growth.
  • Investment decisions are made with a long-term perspective, considering over 10-year IRR for projects.

Track Rallis India — get its next earnings analysis in your feed

How does Rallis India rank vs peers in Fertilizers & Agrochemicals?

Pro feature
ThisRallis India
Rev 5Mar 3

How does Rallis India rank in Fertilizers & Agrochemicals?

Compare Rallis India against every Fertilizers & Agrochemicals company (Q2 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

Others in Fertilizers & Agrochemicals this season

  • Madhya Bharat Agro Products (Q2 FY27)

    Q2 FY27 Revenue: ₹715 crore, up 59% YoY (Page 12, Chairman’s Quote) . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q2 FY27 investo

  • Dhansa Labs (Q2 FY27)

    1,864 crores during H1 FY27. Key results statement takeaways from Dhansa Labs Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Aristo Bio-Tech (Q2 FY27)

    1,168.88 lakh, approximate operating margin is about 5.9% for the quarter. Key results statement takeaways from Aristo Bio-Tech & Lifescience Ltd's Q2 FY27 resu

  • Krishana Phoschem (Q2 FY27)

    Q2 FY27 Revenue: ₹703 crore, a 16% year-on-year (YoY) increase (Page 11). Key investor presentation takeaways from Krishana Phoschem Ltd's Q2 FY27 investor pres

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →